The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 21 results:
Author Title [ Type(Desc)] Year
Filters: Author is Chatzopoulos, Dimitrios  [Clear All Filters]
Journal Article
Kountouras, J., Papaefthymiou A., Polyzos S. A., Liatsos C., Tzitiridou-Chatzopoulou M., Chatzopoulos D., et al. (2022).  Adverse Outcomes of E-cigarette in Inflammatory Bowel Disease.. Dig Dis Sci.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Vardaka E., Kyrailidi F., Mouratidou M. C., et al. (2023).  Autonomic Dysfunction and Somatization in Young Patients With Irritable Bowel Syndrome and Mitral Valve Prolapse Syndrome.. J Neurogastroenterol Motil. 29(3), 403-404.
Chatzopoulos, D., Moralidis E., Markou P., Makris V., & Arsos G. (2008).  Baker's cysts in knees with chronic osteoarthritic pain: a clinical, ultrasonographic, radiographic and scintigraphic evaluation.. Rheumatol Int. 29(2), 141-6.
Kountouras, J., Doulberis M., Polyzos S. A., Kazakos E., Vardaka E., Tzitiridou-Chatzopoulou M., et al. (2022).  Emerging parameters relevant to the management of antimicrobial-resistant Helicobacter pylori infection.. Intern Med J. 52(9), 1654-1655.
Kountouras, J., Boziki M., Gavalas E., Zavos C., Grigoriadis N., Deretzi G., et al. (2009).  Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease.. J Neurol. 256(5), 758-67.
Kountouras, J., Kazakos E., Polyzos S. A., Chatzopoulos D., Tzitiridou-Chatzopoulou M., Doulberis M., et al. (2022).  GM-CSF as a potential candidate of a vaccine-induced reduction of Helicobacter pylori infection.. Helicobacter. 27(3), e12884.
Kountouras, J., Chatzopoulos D., Zavos C., Polyzos S. A., Giartza-Taxidou E., Vardaka E., et al. (2012).  Helicobacter pylori infection might contribute to esophageal adenocarcinoma progress in subpopulations with gastroesophageal reflux disease and Barrett's esophagus.. Helicobacter. 17(5), 402-3.
Ntona, S., Papaefthymiou A., Kountouras J., Gialamprinou D., Kotronis G., Boziki M., et al. (2023).  Impact of nonalcoholic fatty liver disease-related metabolic state on depression.. Neurochem Int. 163, 105484.
Kountouras, J., Boziki M., Gavalas E., Zavos C., Deretzi G., Grigoriadis N., et al. (2009).  Increased cerebrospinal fluid Helicobacter pylori antibody in Alzheimer's disease.. Int J Neurosci. 119(6), 765-77.
Kountouras, J., Kazakos E., Kyrailidi F., Polyzos S. A., Zavos C., Arapoglou S., et al. (2023).  Innate immunity and nonalcoholic fatty liver disease.. Ann Gastroenterol. 36(3), 244-256.
Kountouras, J., Chatzopoulos D., Zavos C., Deretzi G., Polyzos S. A., Gavalas E., et al. (2012).  Ki-67 and Bax expression in esophageal mucosa might have implications in ablative therapies for Barrett's esophagus, dysplasia, and adenocarcinoma.. Surg Endosc. 26(1), 283-4.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Kazakos E., Tzilves D., Touloumtzi M., et al. (2023).  Letter: higher severe outcomes among Helicobacter pylori-related lean patients with non-alcoholic fatty liver disease and metabolic comorbidities.. Aliment Pharmacol Ther. 57(10), 1186-1187.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Liatsos C., Vardaka E., Touloumtzi M., et al. (2022).  Letter to the Editor Regarding "The Association of Helicobacter pylori, Eradication, and Early Complications of Laparoscopic Sleeve Gastrectomy" by Abeid et al.. Obes Surg. 32(6), 2079-2080.
Chatzopoulos, D., Iakovou I., & Moralidis E. (2007).  Marine-Lenhart syndrome and radioiodine-131 treatment.. Thyroid. 17(4), 373-4.
Kountouras, J., Zavos C., Deretzi G., Polyzos S. A., Gavalas E., Tsiaousi E., et al. (2011).  Neuroprotection in glaucoma: is there a future role of Helicobacter pylori eradication?. Exp Eye Res. 92(5), 436-8.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Liatsos C., Tzitiridou-Chatzopoulou M., Chatzopoulos D., et al. (2022).  Potential impact of Helicobacter pylori and metabolic syndrome-related non-alcoholic fatty liver disease on cardio-cerebrovascular disease.. Metabolism. 135, 155276.
Kountouras, J., Doulberis M., Polyzos S. A., Tzitiridou M., Chatzopoulos D., Gialamprinou D., et al. (2022).  A potential impact of Helicobacter pylori-related metabolic syndrome on early and long-term outcomes of bariatric surgery.. Gastrointest Endosc. 96(6), 1088-1089.
Kountouras, J., Kazakos E., Polyzos S. A., Papaefthymiou A., Zavos C., Tzitiridou-Chatzopoulou M., et al. (2023).  Potential impact of trained innate immunity on the pathophysiology of metabolic dysfunction-associated fatty liver disease.. Clin Immunol. 256, 109776.
Kountouras, J., Zavos C., Deretzi G., Gavalas E., Chatzopoulos D., Katsinelos P., et al. (2012).  Potential implications of Helicobacter pylori-related neutrophil-activating protein.. World J Gastroenterol. 18(5), 489-90.
Chatzopoulos, D., Markou P., & Iakovou I. (2006).  [Scintigraphic imaging of knee synovitis in osteoarthritis after intra-articular injection of technetium-99m pertechnetate in the unilateral knee].. Hell J Nucl Med. 9(1), 69-71.
Chatzopoulos, D., Moralidis E., Markou P., & Makris V. (2009).  Yttrium-90 radiation synovectomy in knee osteoarthritis: a prospective assessment at 6 and 12 months.. Nucl Med Commun. 30(6), 472-9.

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.